DRCT post hoc analysis · Small HIV cohort

Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy

M Corley, V Dwaraka, A Pang, D Labbato, R Smith, A Ross Eckard et al.. Nature Communications. 2026.

Published 2026-10-15Sources checked 2026-10-151 sourceEverstack research teamHow we work

In plain language: In HIV-associated lipohypertrophy, semaglutide slowed several epigenetic clocks over 32 weeks.
Limits: Post hoc, small.
Source: doi.org/10.1038/s41467-026-72861-3 · PubMed 42156721 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack.